Dow Down 0.25% Nasdaq Down 0.91%

Advaxis, Inc. (ADXS)

-NasdaqCM
3.13 Down 0.04(1.26%) 10:22AM EDT - Nasdaq Real Time Price
Prev Close:3.17
Open:3.19
Bid:3.13 x 100
Ask:3.16 x 1800
1y Target Est:13.50
Beta:1.16
Next Earnings Date:N/A
Day's Range:3.09 - 3.19
52wk Range:2.46 - 7.59
Volume:15,038
Avg Vol (3m):240,395
Market Cap:61.09M
P/E (ttm):N/A
EPS (ttm):-2.62
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ADXS

Comparison

Symbol% ChgMkt Cap
ADXSDown 1.26%61.09M
BVTI 0.00%N/A
DNDNUp 2.00%237.81M
VICLDown 1.72%101.01M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):61.87
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Oct-14) :-1.16
Quarterly EPS Est (Oct-14) :-0.29
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Advaxis, Inc., a clinical development stage biotechnology company, focuses on developing immunotherapies for cancer and infectious diseases. The company’s Lm -LLO immunotherapy platform technology stimulates the immune system to induce antige... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback